Humulin r and Hepatocellular carcinoma - a phase IV clinical study of FDA data

Summary:

Hepatocellular carcinoma is reported only by a few people who take Humulin R.

The phase IV clinical study analyzes which people take Humulin r and have Hepatocellular carcinoma. It is created by eHealthMe based on reports of 20,849 people who have side effects while taking Humulin r from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 20, 2023

20,849 people reported to have side effects when taking Humulin r.
Among them, 3 people (0.01%) have Hepatocellular carcinoma.

What is Humulin r?

Humulin r has active ingredients of insulin recombinant human. It is often used in type 1 diabetes. eHealthMe is studying from 20,918 Humulin r users for its effectiveness, alternative drugs and more.

What is Hepatocellular carcinoma?

Hepatocellular carcinoma (liver cancer) is found to be associated with 1,049 drugs and 661 conditions by eHealthMe.

Number of Humulin r and Hepatocellular carcinoma reports submitted per year:

Could Humulin r cause Hepatocellular carcinoma?

Gender of people who have Hepatocellular carcinoma when taking Humulin r *:

female: 0.0 %
male: 100 %

Age of people who have Hepatocellular carcinoma when taking Humulin r *:

Common drugs people take besides Humulin r *:

Common side effects people have besides Hepatocellular carcinoma *:

Weakness: 2 people, 66.67%
Delirium (wild excitement): 2 people, 66.67%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 2 people, 66.67%
Peritonitis Bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial): 2 people, 66.67%
Peritoneal Haemorrhage (peritoneal bleeding): 2 people, 66.67%
Neoplasm Malignant (cancer tumour): 2 people, 66.67%
Intestinal Obstruction: 2 people, 66.67%
Hypotension (abnormally low blood pressure): 2 people, 66.67%
Tumor Haemorrhage: 2 people, 66.67%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 2 people, 66.67%

Common conditions people have *:

Stress And Anxiety: 2 people, 66.67%
Insomnia (sleeplessness): 2 people, 66.67%
Pain: 1 person, 33.33%
High Blood Pressure: 1 person, 33.33%
High Blood Cholesterol: 1 person, 33.33%
Anaemia (lack of blood): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Humulin r and have Hepatocellular carcinoma?

Check whether Hepatocellular carcinoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .

Related studies

How severe was Hepatocellular carcinoma and when was it recovered:

Hepatocellular carcinoma in Humulin r

Expand to all the drugs that have ingredients of insulin recombinant human:

Hepatocellular carcinoma and drugs with ingredients of insulin recombinant human

Alternative drugs to, pros and cons of Humulin r:

Humulin r (20,918 reports)

Common Humulin r side effects:

Drug ineffective: 1,623 reports
Diabetes: 1,073 reports
Heart attack: 883 reports
Weight increased: 847 reports
High blood pressure: 774 reports

Browse all side effects of Humulin r:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hepatocellular carcinoma treatments and more:

Hepatocellular carcinoma (23,683 reports)

COVID vaccines that are related to Hepatocellular carcinoma:

Common drugs associated with Hepatocellular carcinoma:

All the drugs that are associated with Hepatocellular carcinoma:

Hepatocellular carcinoma (1,049 drugs)

Common conditions associated with Hepatocellular carcinoma:

All the conditions that are associated with Hepatocellular carcinoma:

Hepatocellular carcinoma (661 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant human (the active ingredients of Humulin r) and Humulin r (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.